Circular Bio-based Europe Joint Undertaking
Overview
Circular Bio-based Europe Joint Undertaking is a €2 billion public-private partnership between the European Union and the Bio-based Industries Consortium that funds research and innovation projects to advance competitive, sustainable, and circular bio-based industries in Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Circe Biotechnologie GmbH | Sep 2026 | Grant | Lead |
| Catalyxx | Jul 2026 | Grant | Co-investor |
| Adamo Foods | May 2026 | Grant | Co-investor |
| Emirates Biotech | Mar 2026 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Circular Bio-based Europe Joint Undertaking based?
Circular Bio-based Europe Joint Undertaking is headquartered in Brussels, Belgium.
When was Circular Bio-based Europe Joint Undertaking founded?
Circular Bio-based Europe Joint Undertaking was founded in 2021.
How many portfolio companies does Circular Bio-based Europe Joint Undertaking have?
Circular Bio-based Europe Joint Undertaking has 34 portfolio companies in Caplight's dataset.
What are some companies in Circular Bio-based Europe Joint Undertaking's portfolio?
Recent investments visible on Caplight include Circe Biotechnologie GmbH, Catalyxx, Catalyxx, Adamo Foods, Emirates Biotech.
What was Circular Bio-based Europe Joint Undertaking's most recent investment?
Circular Bio-based Europe Joint Undertaking's most recent investment on Caplight was in Circe Biotechnologie GmbH in 2026.
What sectors does Circular Bio-based Europe Joint Undertaking focus on?
Circular Bio-based Europe Joint Undertaking focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Consumer & Commerce, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Consumer & Commerce, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Circular Bio-based Europe Joint Undertaking focus on?
Circular Bio-based Europe Joint Undertaking typically invests at the MultiStage stage.
What is Circular Bio-based Europe Joint Undertaking's AUM?
Circular Bio-based Europe Joint Undertaking's assets under management are estimated between $2.1B and $2.1B.